Alexandra Leary

ScholarGPS® ID: 66289024590514

Affiliation

Institut National de la Santé et de la Recherche Médicale, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

286

Predicted Citations

12,334

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer (journal article) Blanc‐Durand, Félix \| Camilleri, Geraldine M. \| Bayle, Arnaud \| Aldea, Mihaela \| Vasseur, Damien \| Ouali, Kaissa \| Michels, Judith \| Pautier, Patricia \| Nicotra, Claudio \| Ngo‐Camus, Maud \| ... \| Leary, Alexandra Cancer (2024). 10.1002/cncr.35381 Cited by (1) \| Cite \| Source
Updates in the Use of Targeted Therapies for Gynecologic Cancers (journal article) Cantillo, Evelyn \| Blanc-Durand, Felix \| Leary, Alexandra \| Slomovitz, Brian M. \| Fuh, Katherine \| Washington, Christina American Society of Clinical Oncology Educational Book, volume 44, issue 3 (2024). 10.1200/EDBK_438582 Cite \| Source
53P Description of BRCA mutated high-grade ovarian cancer demonstrating primary resistance to first-line platinum in the French national multicenter ESME database (journal article) Leary, A. \| Fouquier, A. \| Ray-Coquard, I.L. \| Rodrigues, M.J. \| Frenel, J-S. \| Sabatier, R. \| Petit, T. \| Guillemet, C. \| de la Motte Rouge, T. \| Colombo, P-E. \| ... \| Camilleri, G.M. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103560 Cite \| Source
Exploring the tumor microenvironment (TME) in patients with mismatch repair-deficient (MMRd) endometrial cancer (EC) undergoing immune checkpoint inhibitor (ICI) therapy: Proteomic insights into immune resistance mechanisms. (journal article) Grau Béjar, Juan Francisco \| Zeng, Qinghe \| Mehnert, Martin \| Colomba, Emeline \| Genestie, Catherine \| Le Formal, Audrey \| Edmond, Elodie \| Lachaud, Antoine Amaury \| Pautier, Patricia \| Michels, Judith \| ... \| Leary, Alexandra Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5609-5609 (2024). 10.1200/JCO.2024.42.16_suppl.5609 Cite \| Source
Efficacy of olaparib combined to metronomic cyclophosphamide and metformin in patients with recurrent advanced/metastatic endometrial by molecular subtypes: ENDOLA phase I/II trial. (journal article) You, Benoit \| Leary, Alexandra \| Follana, Philippe \| Abdeddaim, Cyril \| Joly, Florence \| Bin, Sylvie \| Villeneuve, Laurent \| Alexandre, Marine \| Bonjour, Maxime \| Schwiertz, Vérane \| ... \| Callens, Celine Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5605-5605 (2024). 10.1200/JCO.2024.42.16_suppl.5605 Cite \| Source
Clinico-molecular predictors of exceptional response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC). (journal article) Barraud, Solenn \| Roussel-Simonin, Cyril \| Leary, Alexandra Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5539-5539 (2024). 10.1200/JCO.2024.42.16_suppl.5539 Cite \| Source
An evaluation of cell-free tumor DNA from 20 mL of peritoneal fluid for homologous recombination deficiency (HRD) testing in newly diagnosed ovarian cancer (OC). (journal article) Roussel-Simonin, Cyril \| Tang, Rosaline \| Blanc-Durand, Felix \| Vasseur, Damien \| Le Formal, Audrey \| Chardin, Laure \| Yaniz, Elisa \| Gouy, Sebastien \| Scherier, Stephanie \| Maulard, Amandine \| ... \| Leary, Alexandra Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5577-5577 (2024). 10.1200/JCO.2024.42.16_suppl.5577 Cite \| Source
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Survival outcomes and immune correlates. (journal article) Leary, Alexandra \| Chardin, Laure \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Lebreton, Coriolan \| Savoye, Aude-Marie \| Oudard, Stephane \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5569-5569 (2024). 10.1200/JCO.2024.42.16_suppl.5569 Cite \| Source
Targeting the CD47/TSP-1 axis: A promising strategy for patients with ovarian cancer (OC) that relapses on PARP inhibitors (PARPi). (journal article) Leary, Alexandra \| Jeanne, Albin \| Etiennot, Marion \| Henry, Aubéri \| Drelon, Coralie \| Schneider, Christophe \| Moniot, Aurélie \| Dedieu, Stéphane Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5568-5568 (2024). 10.1200/JCO.2024.42.16_suppl.5568 Cite \| Source
Unveiling the unique identity of clear-cell endometrial cancer (CCEC): A comprehensive comparative analysis with ovarian counterpart and other endometrial subtypes. (journal article) Blanc-Durand, Felix \| Ngoi, Natalie \| Rouleau, Etienne \| Pautier, Patricia \| Michels, Judith \| Ouali, Kaïssa \| Genestie, Catherine \| Lim, Yi Wan \| Lim, Diana \| Wijaya, Silvana Talisa \| ... \| Tan, David Shao Peng Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5521-5521 (2024). 10.1200/JCO.2024.42.16_suppl.5521 Cite \| Source
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection (journal article) Sanson, Claire \| Roosen, Alice \| Faron, Matthieu \| Zaccarini, François \| Maulard, Amandine \| Scherier, Stephanie \| Pautier, Patricia \| Leary, Alexandra \| Chargari, Cyrus \| Espenel, Sophie \| ... \| Gouy, Sebastien International Journal of Gynecologic Cancer, volume 34, issue 5, pages 730-737 (2024). 10.1136/ijgc-2023-005158 Cited by (1) \| Cite \| Source
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group (journal article) Freyer, Gilles \| Floquet, Anne \| Tredan, Olivier \| Carrot, Aurore \| Langlois-Jacques, Carole \| Lopez, Jonathan \| Selle, Frédéric \| Abdeddaim, Cyril \| Leary, Alexandra \| Dubot-Poitelon, Coraline \| ... \| Lamuraglia, Michele Nature Communications, volume 15, issue 1 (2024). 10.1038/s41467-024-45974-w Cited by (2) \| Cite \| Source
Stratégies thérapeutiques post-chirurgicales actuelles dans les cancers de l’ovaire en première ligne de traitement (journal article) Ouali, Kaïssa \| Michels, Judith \| Blanc-Durand, Felix \| Leary, Alexandra \| Kfoury, Maria \| Genestie, Catherine \| Morice, Philippe \| Zaccarini, François \| Scherrier, Stéphanie \| Gouy, Sebastien \| ... \| Pautier, Patricia Bulletin du Cancer, volume 111, issue 3, pages 267-276 (2024). 10.1016/j.bulcan.2023.01.020 Cite \| Source
Targeting the immune microenvironment in ovarian cancer therapy—mission impossible? (journal article) Blanc-Durand, F. \| Pautier, P. \| Michels, J. \| Leary, A. ESMO Open, volume 9, issue 3, pages 102936- (2024). 10.1016/j.esmoop.2024.102936 Cite \| Source
360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trial (conference) Garcia, Yolanda Garcia \| Gorp, Toon Van \| Konecny, Gottfried E \| Leary, Alexandra \| Santin, Alessandro D \| Crusz, Shanthini Mary \| Mantia-Smaldone, Gina \| Lorusso, Domenica \| Colombo, Nicoletta \| Thomes-Pepin, Jessica \| ... \| Moore, Kathleen N ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.43 Cite \| Source
531 Loss-of-heterozygosity as a biomarker for genomic instability and poor outcomes in endometrial cancer (conference) Blanc-Durand, Felix \| Vasseur, Damien \| Pautier, Patricia \| Michels, Judith \| Rouleau, Etienne \| Lim, Yi Wan \| Lim, Siew Eng \| Lim, Diana \| Wijaya, Silvana \| Sachdeva, Manavi \| ... \| Tan, David Sp ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.979 Cite \| Source
1276 The Diagnostic landscape and clinical outcomes associated with homologous recombinant deficiency (indicator one): results and one-year trends from a survey of physicians and molecular pathologists (conference) Coleman, Robert L \| Hada, Manila \| Iu, Crystal \| John, Ellie \| Sundin, Tabetha \| Schweikert, Bernd \| Clark, Dayna R \| Leary, Alexandra ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.820 Cite \| Source
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid (journal article) Roussel-Simonin, Cyril \| Blanc-Durand, Felix \| Tang, Roseline \| Vasseur, Damien \| Le Formal, Audrey \| Chardin, Laure \| Yaniz, Elisa \| Gouy, Sébastien \| Maulard, Amandine \| Scherier, Stéphanie \| ... \| Leary, Alexandra Molecular Cancer, volume 22, issue 1 (2023). 10.1186/s12943-023-01864-1 Cite \| Source
RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test (journal article) Kramer, Claire JH \| Llop‐Guevara, Alba \| Yaniz‐Galende, Elisa \| Pellegrino, Benedetta \| ter Haar, Natalja T \| Herencia‐Ropero, Andrea \| Campanini, Nicoletta \| Musolino, Antonino \| Bosse, Tjalling \| Leary, Alexandra \| ... \| Vreeswijk, Maaike PG The Journal of Pathology: Clinical Research, volume 9, issue 6, pages 442-448 (2023). 10.1002/cjp2.336 Cited by (1) \| Cite \| Source
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients (journal article) Kfoury, Maria \| Hazzaz, Reda El \| Sanson, Claire \| Durand, Felix Blanc \| Michels, Judith \| Blameble, Emeline Colomba \| Tang, Roseline \| Le Formal, Audrey \| Lecerf, Elodie \| Gouy, Sebastien \| ... \| Leary, Alexandra Biomarker Research, volume 11, issue 1 (2023). 10.1186/s40364-023-00533-1 Cited by (1) \| Cite \| Source